Catalent
CTLT
#1586
Rank
S$14.57 B
Marketcap
$80.31
Share price
1.42%
Change (1 day)
50.37%
Change (1 year)
Catalent is an American pharmaceutical contract research and development company.

Catalent (CTLT) - Cash on Hand

Cash on Hand as of September 2024 : S$0.44 Billion

According to Catalent's latest financial reports the company has S$0.44 Billion in cash and cash equivalents.
A companyโ€™s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.

Catalent - Cash on Hand chart (from 2013 to 2024)

Cash on Hand by year

Year Cash on Hand Change
2023-06-30S$0.37 B-49.32%
2022-06-30S$0.74 B-42.38%
2021-06-30S$1.30 B-2.07%
2020-06-30S$1.32 B184.18%
2019-06-30S$0.46 B-16.42%
2018-06-30S$0.55 B32.16%
2017-06-30S$0.42 B126.67%
2016-06-30S$0.18 B-8.42%
2015-06-30S$0.20 B119.18%
2014-06-30S$92.97 M-31.04%
2013-06-30S$0.13 B-23.45%
2012-06-30S$0.17 B

Cash on Hand for similar companies or competitors

Company Cash on Hand differencediff. Country
S$0.54 B 20.36%๐Ÿ‡บ๐Ÿ‡ธ USA
S$0.23 B-48.52%๐Ÿ‡บ๐Ÿ‡ธ USA
S$3.51 B 681.53%๐Ÿ‡ฎ๐Ÿ‡ช Ireland
S$0.43 B-3.67%๐Ÿ‡บ๐Ÿ‡ธ USA